• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD Phaseal; Closed antineoplastic and hazardous drug reconstitution and transfer system

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD Phaseal; Closed antineoplastic and hazardous drug reconstitution and transfer system Back to Search Results
Catalog Number 515629
Medical Device Problem Codes Disconnection (1171); Leak/Splash (1354)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/09/2026
Type of Reportable Event Malfunction
Event or Problem Description
No additional information.
 
Additional Manufacturer Narrative
Investigation summary: the device history record (dhr) for lot 2603509, reference 515629 product set c83-o was reviewed, and no deviations or non-conformances were identified that could be related to the reported event.A review of the applicable risk document indicates that the potential risk of the reported event was assessed appropriately in the risk management documentation.Three retained samples of the c83-o set, lot 2603509, reference 515629, were received for evaluation of the condition reported by the customer.A detailed visual inspection was performed on all three returned samples.No anomalies, damage, or deviations were identified that could be associated with the reported failure mode.As part of the investigation, functional testing was conducted by connecting each of the three retained samples to an n40-o injector.All evaluated units were successfully connected to the luer adapter, achieving proper engagement and locking as intended by the product.No abnormalities or performance issues were observed during testing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD Phaseal
Common Device Name
Closed antineoplastic and hazardous drug reconstitution and transfer system
Manufacturer (Section D)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
Manufacturer (Section G)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
+1(847)393-5694
MDR Report Key50862364
Report Number3003152976-2026-00448
Device Sequence Number10025618
Product Code ONB
UDI-Device Identifier00382905156298
UDI-Public(01)00382905156298(11)260330(17)280229(10)2603509
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K250059
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/29/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number515629
Device Lot Number2603509
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/09/2026
Supplement Date Received by Manufacturer09/29/2026
Initial Report FDA Received Date09/22/2026
Supplement Report FDA Received Date09/30/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/30/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-